Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Fludzoparib" and Anti-angiogenic × eribulin × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 13 Triple Negative Breast Neoplasms 6 Neoplasm Metastasis 3 Urinary Bladder Neoplasms 2 Urethral Neoplasms 1 Ureteral Neoplasms 1 Recurrence 1 Hemangiosarcoma 1 Hemangioendothelioma, Epithelioid 1 HER2-low Breast Cancer 1 Carcinoma, Transitional Cell 1 Brest Cancer 1 Brain Neoplasms 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡